Efficiency of singlon (montelukast) in treatment of allergic rhinitis in children
Бесплатный доступ
New information is presented on the use of an inhibitor of leucotriene receptors - Singlon (montelucast) in the treatment of allergic rhinitis in children. Singlon, given as a chewable tablet, is effective in 72.3% of patients aged 6 to 14 with AR
Allergic rhinitis, children, treatment, singlon
Короткий адрес: https://sciup.org/14125044
IDR: 14125044 | DOI: 10.24411/2181-0443/2020-10090
Статья обзорная
